CM-272
CAS No. 1846570-31-7
CM-272 ( CM272;CM 272 )
Catalog No. M12852 CAS No. 1846570-31-7
CM-272 (CM272)is a novel potent, selective and reversible dual inhibitor of G9a/DNMTs with IC50 of 8 nM and 382 nM for G9a and DNMT1, respectively.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
5MG | 147 | In Stock |
|
10MG | 260 | In Stock |
|
25MG | 484 | In Stock |
|
50MG | 699 | In Stock |
|
100MG | 981 | In Stock |
|
200MG | Get Quote | In Stock |
|
500MG | Get Quote | In Stock |
|
1G | Get Quote | In Stock |
|
Biological Information
-
Product NameCM-272
-
NoteResearch use only, not for human use.
-
Brief DescriptionCM-272 (CM272)is a novel potent, selective and reversible dual inhibitor of G9a/DNMTs with IC50 of 8 nM and 382 nM for G9a and DNMT1, respectively.
-
DescriptionCM-272 (CM272)is a novel potent, selective and reversible dual inhibitor of G9a/DNMTs with IC50 of 8 nM and 382 nM for G9a and DNMT1, respectively; also inhibits DNMT3A/3B/GLP with IC50 of 85/1,200/2 nM, respectively; inhibits cell proliferation and promotes apoptosis in different haematological neoplasias (AML, ALL and DLBCL); significantly prolongs survival of AML, ALL and DLBCL xenogeneic models.
-
SynonymsCM272;CM 272
-
PathwayChromatin/Epigenetic
-
TargetHMTase
-
RecptorHMTase
-
Research AreaCancer
-
Indication——
Chemical Information
-
CAS Number1846570-31-7
-
Formula Weight478.64
-
Molecular FormulaC28H38N4O3
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCC1=CC=C(O1)C2=NC3=CC(=C(C=C3C(=C2)NC4CCN(CC4)C)OC)OCCCN5CCCC5
-
Chemical Name6-methoxy-2-(5-methylfuran-2-yl)-N-(1-methylpiperidin-4-yl)-7-(3-(pyrrolidin-1-yl)propoxy)quinolin-4-amine
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. San José-Enériz E, et al. Nat Commun. 2017 May 26;8:15424.
2.Bárcena-Varela M, et al. Hepatology. 2018 Jul 16. doi: 10.1002/hep.30168.
2.Bárcena-Varela M, et al. Hepatology. 2018 Jul 16. doi: 10.1002/hep.30168.
molnova catalog
related products
-
WDR5 WIN site inhibi...
WDR5 WIN site inhibitor C6 is a potent, specific WIN (WDR5 interaction) site inhibitor of WDR5 with Kd of 0.1 nM.
-
C7280948
C-7280948 is a PRMT1 inhibitor.
-
NV03
NV03 is a small-molecule antagonist of the H3K9me3 binding to UHRF1 tandem tudor domain with Kd of 2.4 uM.